AU5615200A - Cell-based assay for screening cox-2 inhibitors - Google Patents
Cell-based assay for screening cox-2 inhibitorsInfo
- Publication number
- AU5615200A AU5615200A AU56152/00A AU5615200A AU5615200A AU 5615200 A AU5615200 A AU 5615200A AU 56152/00 A AU56152/00 A AU 56152/00A AU 5615200 A AU5615200 A AU 5615200A AU 5615200 A AU5615200 A AU 5615200A
- Authority
- AU
- Australia
- Prior art keywords
- cox
- inhibitors
- screening
- cell
- based assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000423 cell based assay Methods 0.000 title 1
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13956999P | 1999-06-16 | 1999-06-16 | |
| US60139569 | 1999-06-16 | ||
| PCT/US2000/016486 WO2000077245A1 (en) | 1999-06-16 | 2000-06-15 | Cell-based assay for screening cox-2 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5615200A true AU5615200A (en) | 2001-01-02 |
Family
ID=22487303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU56152/00A Abandoned AU5615200A (en) | 1999-06-16 | 2000-06-15 | Cell-based assay for screening cox-2 inhibitors |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1187934A4 (en) |
| AU (1) | AU5615200A (en) |
| CA (1) | CA2374676A1 (en) |
| WO (1) | WO2000077245A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2690188C2 (en) * | 2017-05-26 | 2019-05-31 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | New multitarget preparation for treating diseases in mammals |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5543297A (en) * | 1992-12-22 | 1996-08-06 | Merck Frosst Canada, Inc. | Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity |
| AT402732B (en) * | 1996-02-16 | 1997-08-25 | Nycomed Austria Gmbh | Use of the human megakaryocytic cell line dami for identifying and determining substances for inhibiting the enzymatic activity of the enzyme cyclooxygenase-1 |
| AT402936B (en) * | 1996-05-29 | 1997-09-25 | Nycomed Austria Gmbh | Use of a human cell line for identifying and determining substances for inhibiting the induction of the expression of the cyclooxygenase-2 gene |
-
2000
- 2000-06-15 EP EP00941446A patent/EP1187934A4/en not_active Withdrawn
- 2000-06-15 AU AU56152/00A patent/AU5615200A/en not_active Abandoned
- 2000-06-15 WO PCT/US2000/016486 patent/WO2000077245A1/en not_active Application Discontinuation
- 2000-06-15 CA CA002374676A patent/CA2374676A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2374676A1 (en) | 2000-12-21 |
| WO2000077245A1 (en) | 2000-12-21 |
| EP1187934A4 (en) | 2002-07-31 |
| WO2000077245A9 (en) | 2002-06-20 |
| EP1187934A1 (en) | 2002-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2777599A (en) | Automated assaying device | |
| AU5429399A (en) | Fluorescent assay for biological systems | |
| AU9586798A (en) | Analyte assaying device | |
| AU3704200A (en) | Viability assay for sporocyst-forming protozoa | |
| AU5324099A (en) | Methods for predicting drug response | |
| AU2073801A (en) | A system for cell-based screening | |
| AU7827500A (en) | Systems for detecting analytes | |
| AU1656401A (en) | A system for cell-based screening | |
| AU5459000A (en) | Highly sensitive biological agent probe | |
| AU2001274829A1 (en) | Method for detection of biological related materials using biomarkers | |
| AU5781800A (en) | Methods and compositions for assaying analytes | |
| AU3162500A (en) | Homogeneous fluorescence assay | |
| AU3745799A (en) | Assays for the detection of microtubule depolymerization inhibitors | |
| AU2002332088A1 (en) | Methods and reagents for improved cell-based assays | |
| AU4580800A (en) | Imaging assay analysis for microsamples | |
| AU3178200A (en) | Genetic analysis | |
| AU4586700A (en) | Improved assay and reagents therefor | |
| AU4724099A (en) | Immobilized reagents for kinase assays | |
| AU5763100A (en) | Non-destructive cell-based assay | |
| AU2002222129A1 (en) | Linear array devices for detecting an analyte or for screening | |
| AU5615200A (en) | Cell-based assay for screening cox-2 inhibitors | |
| IL138532A0 (en) | Fluorescent assay for topoisomerase inhibitors | |
| WO2001029756A8 (en) | Autogrid analysis | |
| AUPQ145599A0 (en) | Analyte detection | |
| AU1134601A (en) | Assay method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |